Diagnosis of Trypanosoma Cruzi Infection

American Trypanosomiasis

Volumn , Issue , 2010, Pages 743-792

  Luquetti, Alejandro O ^a   Schmuñis, Gabriel A ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863792894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384876-5.00028-9     Document Type: Chapter

References (210)

1. Affranchino J.L., Ibañez C.F., Luquetti A.O., Rassi A., Reyes M.B., Macina R.A., et al. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol. Biochem. Parasitol. 1989, 34:221-228.
2. Almeida I.C., Rodrigues E.G., Travassos L.R. Chemoluminescent immunoassays: discrimination between the reactivities of natural and human patients antibodies from eukaryotic pathogens, Trypanosoma cruzi and Paracoccidioides brasiliensis. J. Clin. Lab. Anal. 1994, 8:424-431.
3. Almeida I.C., Covas D.T., Soussumi L.M.T., Travassos L.R. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 1997, 37:850-857.
4. Almeida J.O. Isofixation curves as a method for standardizing quantitative complement fixation tests. J. Immunol. 1956, 7:259-263.
5. Almeida J.O., Fife E.H. Metodos de fijación del complemento estandarizado cuantitativamente para la evaluacion critica de antigenos preparados con Trypanosoma cruzi. Org. Panam. Salud Publ. Sci. 319, Washington DC. 1976.
6. Amato Neto V., Dias A.F. Comentários sobre caso de transmissão da doença de Chagas por transfusão de sangue e longo período de incubação. Rev. Soc. Bras. Med. Trop. 1969, 3:273-275.
7. Amato Neto V. Conduta frente ao doador Chagasico. Rev. Soc. Bras. Med. Trop. 1993, 26(Suppl. 1):86-87.
8. Andrade A.L.S.S., Martelli C.M.T., Luquetti A.O., Oliveira O.S., Almeida e Silva S., Zicker F. Serologic screenig for Trypanosoma cruzi among blood donors in Central Brazil. Bull. PAHO 1992, 26:157-164.
9. Andrade A.L.S.S., Zicker F., Oliveira R.M., Silva S.A., Luquetti A.O., Travassos L.R., et al. Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996, 348:1407-1413.
10. Chagas disease in Chile. Certification of interruption of transmission. Week. Epid. Rec. 2000, 2:10-12. Anonymous.
11. Anonymous, 2008. Workshop and Symposium. Estandarizacion y Validacion del uso Clinico de la Reaccion en Cadena de la Polimerasa Para Deteccion de Infeccion por Trypanosoma cruzi, 17-22 de noviembre de 2008, Buenos Aires, Argentina. http://www.ingebi-conicet.gov.ar.
12. Arcavi M., Orfur G., Griemberg G. Incidencia de la infeccion Chagasica en embarazadas y recien nacidos en area no endemica. Medicina (Bs Aires) 1993, 53:217-222.
13. Ashall F., Yip-Chuck D.A.M., Luquetti A.O., Miles M.A. Radiolabeled total parasite DNA probe specifically detects Trypanosoma cruzi in mammalian blood. J. Clin. Microbiol. 1988, 26:576-578.
14. Assal A., Aznar C. Chagas disease screening in the French blood donor population. Screening assays and donor selection. Enf. Emerg. 2007, 9(Suppl. 1):38-40.
15. Atias A., Lorca M., Canales M., Mercado R., Reyes V., Child R. Enfermedad de Chagas: transmisión por transfusión sanguinea en Chile. Bol. Hosp. San Juan Dios. (Santiago) 1984, 31:301-306.
16. Avila H., Borges-Pereira J., Thiermann O., De Paiva E., Degrave W., Morel C.M., et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J. Clin. Microbiol. 1993, 31:2421-2426.
17. Azogue E., Lafuente C., Darras C.H. Congenital Chagas' disease in Bolivia: epidemiological aspects and pathological findings. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:176-180.
18. Baracchini O., Costa A., Carboni J. Emprego do calor e do metanol no preparo do antigeno de Trypanososma cruzi. Hospital 1965, 68:193-199.
19. Batista S.M., Santos U.M. Methyl antigen from Trypanososma cruzi culture. Hospital 1959, 56:1045-1051.
20. Beltran M.D., Ayala M.G. Evaluacion externa de los resultados serologicos en los bancos de sangre de Colombia. Rev. Salud. Publica. 2003, 13:138-143.
21. Bergendi L., Knierim F., Apt W. Trypanosoma cruzi: immunological properties of a soluble extract of culture forms. Exp. Parasitol. 1970, 28:258-262.
22. Bern C., Verastegui M., Gilman R.H., Lafuente C., Galdos-Cardenas G., Calderon M., et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin. Infect. Dis. 2009, 49:1667-1674.
23. Bergoglio R.M. Enfermedad de Chagas postransfusional. Experiencia clínica de 48 casos. Prensa Med. Argent. 1984, 71:49-52.
24. Bittencourt A.L. Placentite chagasica e transmissao congenita da doenca de Chagas. Rev. Inst. Med. Trop. Sao Paulo 1963, 5:62-67.
25. Bittencourt A.L. Transmissao congenita da doenca de Chagas. Gaz. Med. Bahia. 1967, 67:39-44.
26. Bittencourt A.L. Congenital Chagas'disease. A review. Am. J. Dis. Child. 1976, 130:97-103.
27. Bittencourt A.L., Barbosa H.S. Incidenca da transmissao congenita da doenca de Chagas em abortos. Rev. Inst. Med. Trop. Sao Paulo 1972, 14:257-259.
28. Blanco S., Segura E.L., Cura E., Chuit R., Tulian L., Flores I., et al. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop. Med. Int. Health 2000, 5:293-301.
29. Bolis M. Comparativo de Legislaciones Sobre Sangre Segura 2009, Organizacion Panamericana de la Salud, Washington DC, http://new.paho.org/hq/index.php?option=com_content&task=view&ld =1466&Itemid=1270&lang=en. THS/EV-2005/009, Acceso 3-12-10, 2009.
30. Borges-Pereira J., Willcox H.P., Coura J.R. Imunofluorescência indireta na infecção chagásica crônica. III. Emprego de cepa de T. cruzi e soros do mesmo paciente. Rev. Soc. Bras. Med. Trop. 1987, 20(Suppl. II):50.
31. Brener Z. Laboratory-acquired Chagas' disease: an endemic disease among parasitologists?. In: Genes and Antigens of Parasites: A Laboratory Manual 1984, Fundação Oswaldo Cruz, pp. 3-9.
32. Brumpt E. Le xénodiagnostic. Application au diagnostic de quelques infections parasitaires et en particulier a la Trypanosomose de Chagas. Bull. Soc. Pat. Exot. 1914, 7:706-710.
33. Brutus L., Schneider D., Postigo J., Delgado W., Mollinedo S., Chipaux J.P. Evidence of congenital transmission of Trypanosoma cruzi in a vector free area of Bolivia. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1159-1160.
34. Brutus L., Schneider D., Postigo J., Romero M., Santalla J., Chipaux J.P. Congenital Chagas disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop. 2008, 106:195-199.
35. Budzko D.B., Kierszenbaum F. Isolation of Trypanosoma cruzi from blood. J. Parasitol. 1974, 60:1037-1038.
36. Cabral H.R.A. Rheumatoid factors and Chagas' disease. Science 1982, 219:1026.
37. Camargo M.E. Fluorescent antibody test for the diagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev. Inst. Med. Trop. São Paulo 1966, 8:227-234.
38. Camargo M.E., Funayama Takeda G.K. Diagnostico de laboratorio. Trypanososma cruzi e doenca de Chagas 1979, 175-198. Ganabara Koogan, Rio de Janeiro. Z. Brener, Z. Andrade (Eds.).
39. Camargo M.E., Guimaraes M.C.S., Peres B.A., Hoshino-Shimizu S. Antigenic fractionation and development of new antigens. In: International Symposium of New Approaches in American Trypanosomiasis Research 1976, Pan American Health Organization Sci. Pub, 138, 212-215.
40. Camargo M.E., Silva G.R, Castilho E.A, Silveira A.C. Inquérito sorológico da prevalência de infecção chagásica no Brasil. Rev. Inst. Med. Trop. São Paulo 1984, 26:192-204.
41. Camargo M.E., Segura E.I., Kagan I.G., Souza J.M.P., Carralbeiro J.R., Yanovsky J.E., et al. Three years of collaboration on the standardization of Chagas' disease serodiagnosis in the Americas: an appraisal. PAHO Bull. 1986, 20:233-244.
42. Carlier Y., Torrico F. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop. 2003, 36:767-771.
43. Castro A.M., Luquetti A.O., Rassi A., Rassi G.G., Chiari E., Galvão L.M.C. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol. Res. 2002, 88:894-900.
44. Editorial note to: blood donor screening for Chagas disease-United States, 2006-2007. Morb. Mortal. Wkly. Rep. 2007, 56:144-145. Centers for Disease Control and Prevention (CDC).
45. Cerisola J.A. Valor del inmunodiagnostico en la infeccion Chagasica. Simposio Internacional sobre Enfermedad de Chagas 1972, Sociedad Argentina de Parasitologia, Buenos Aires, Diciembre. pp. 115-124.
46. Cerisola J.A., Chaben M.F., Lazari J.O. Test de hemaglutinación para el diagnóstico de la enfermedad de Chagas. Prensa Méd. Argent. 1962, 49:1761-1767.
47. Cerisola J.A., Del Prado C.E., Rohwedder R., Bozzini J.P. Chritidia triatomae n. sp. found in Triatoma infestans from Argentina. J. Protozool. 1971, 18:503-506.
48. Cerisola J.A., Rabinovich A., Alvarez M., Di Corleto C.A., Pruneda J. Enfermedad de Chagas y la transfusión de sangre. Bol. Of. Sanit. Panam. 1972, 73:203-221.
49. Cerisola J.A., Rohwedder R., Segura E.L., Del Prado C.E., Alvarez M., Martini G.J.W. El xenodiagnóstico. Buenos Aires. Imp. Inst. Nac. Invest. Cardiovasc. 1974, 157.
50. Chapman M.D., Snary D., Miles M.A. Quantitative differences in the expression of a 72,000 molecular weight cell surface glycoprotein (GP72) in Trypanosoma cruzi zymodemes. J. Immunol. 1984, 132:3149-3153.
51. Chiari E., Brener Z. Contribuição ao diagnóstico parasitológico da doença de Chagas na sua fase crônica. Rev. Inst. Med. Trop. São Paulo 1966, 8:134-138.
52. Chiari E., Dias J.C.P., Lana M., Chiari C.A. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev. Soc. Bras. Med. Trop. 1989, 22:19-23.
53. Contreras M.C., Schenone H., Borgono JM, Salinas P., Sandoval L., Rojas A., et al. Infeccion Chagasica en donantes de sangre de hospitales de las regiones endemicas (1982-1987). Trascendencia epidemiologica del problema. Bol. Chil. Parasitol. 1992, 47:10-15.
54. Corral R.S., Altcheh J., Alexandre S.R., Grinstein S., Freilij H., Katzin A.M. Detection and characterization of antigens in urine of patients with acute, congenital, and chronic Chagas. J. Clin. Microbiol. 1996, 34:1957-1962.
55. Cura E., Wendel S. Manual de Procedimientos de Control de Calidad Para los Laboratórios de Serologia de los Bancos de Sangre, Washington 1994, Organización Panamericana de la Salud.
56. D'Alessandro-Bacigalupo A., Saravia N.G. Trypanosoma rangeli. Parasitic Protozoa 1992, 2:1-54. Academic Press, New York.
57. Decreto Real 1088/2005. 2005. Boletín Oficial del Estado del 20 de Septiembre 2005. num 225, 31288-304.
58. Dias J.C.P. Mecanismos de transmissao. Trypanosoma cruzi e doenca de Chagas 1979, Guanabara Koogan, Rio de Janeiro. Z. Brener, Z.A. Andrade (Eds.).
59. Dias, J.C.P., 1992. Chagas' disease and blood transfusion in endemic areas. In: Wendel, S., Brener, Z., Camargo, M.E., Rassi, A. (Eds.), Chagas' Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine. pp. 135-142.
60. Dias J.C.P., Brener S. Chagas' disease and blood transfusion. Mem. Inst. Oswaldo Cruz 1984, 79(Suppl.):139-147.
61. Du K. The quest for quality blood banking program in the new millennium the American way. Int. J. Hematol. 2002, 76(Suppl. 2):258-262.
62. Fife E.H., Muschel L.H. Fluorescent antibody technic for serodiagnosis of Trypanosoma cruzi infection. Proc. Soc. Exp. Biol. Med. 1959, 101:540-543.
63. Fife E.H., Kent J.F. Protein and carbohydrate complement fixing antigens of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1960, 9:512-517.
64. Flores-Chavez M., Faez Y., Olalla J.M., Cruz I., Garate T., Rodriguez M., et al. Fatal congenital Chagas disease in a non endemic area: a case report. Cases J. 2008, 1:302. Available at:http//www.casesjournsal.com/content/1/1302.
65. Franco Y.B.A., Silva I.G., Rassi A., Rocha A.C.R.G., Silva H.H.G., Rassi G.G. Correlação entre a positividade do xenodiagnóstico artificial e a quantidade de sangue e triatomíneos utilizados no exame, em pacientes chagásicos crônicos. Rev. Soc. Bras. Med. Trop. 2002, 35:29-33.
66. Freilij H., Muller L., Cappa S.M.G. Direct micromethod for diagnosis of acute and congenital Chagas' disease. J. Clin. Microbiol. 1983, 18:327-330.
67. Freilij H., Altcheh J., Storino R. Chagas congenito. Enfermedad de Chagas 1994, 247-278. Mosby, Buenos Aires. R. Storino, J. Milei (Eds.).
68. Freitas J.L.P. Reacao de fixacao do complemento para o diagnostico da molestia de Chagas pela tecnica quantitativa. Arch. Hig. (Sao Paulo) 1951, 16:55-94.
69. Freitas J.L.P., Almeida J.O. Nova tecnica de fixacao do complemento para molestia de Chagas. Reacao quantitativa com antigeno gelificado de culturas de Trypanosoma cruzi. Hospital 1949, 35:787-800.
70. Galvão L.M.C., Nunes R.M.B., Cancado J.R., Brener Z., Krettli A.U. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:220-223.
71. Garcia A., Bahamonde M., Verdugo S., Correa J., Pastene C., Solari A., et al. Trypanosoma cruzi transplacental infection: situation in Chile. Rev. Med. Chil. 2001, 129:330-332.
72. Goncalves J.M., Yamaha T. Immunochemincal polysaccharide from Trypanosoma cruzi. J. Trop. Med. Hyg. 1969, 72:38-44.
73. Gonzalez Cappa S.M., Kagan I.G. Antigenicity of fractions of a somatic antigen of Trypanosoma cruzi. J. Parasitol. 1973, 59:1080-1094.
74. Gonzalez A., Prediger E., Huecas M.E, Nogueira N., Lizardi P.M. Minichromosomal repetitive DNA in Trypanosoma cruzi: its use in a high-sensitivity parasite detection assay. Proc. Natl. Acad. Sci. USA. 1984, 81:3356-3360.
75. Goodman C., Chan S., Collins P., Haught R., Chen Y.J. Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment. Final report. Transfusion 2003, 43(Suppl.):3S-46S.
76. Grill D., Elizari M., Szarfman A., Urman J., Schmunis G.A. Anticuerpos anti Trypanosoma cruzi en recien nacidos normales hijos de madres infectadas. Medicina (B. Aires) 1976, 36:158-159.
77. Guarro A., El-Kassab H., Jorba J.M., Lobato A., Castro M., Martin C., et al. Un caso de transmisión congénita de la enfermedad de Chagas en Cataluña. Enferm. Emerg. 2007, 9:28-35.
78. Guerreiro C., Machado A. Da reação de Bordet e Gengou na moléstia de Carlos Chagas como elemento diagnostico. Bras. Med. 1913, 27:225-226.
79. Gurtler R.E., Segura E.L., Cohen J.E. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg. Infect. Dis. 2003, 9:29-32.
80. Gutiérrez R., Angulo V.M., Tarazona Z., Britto C., Fernandes O. Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area. Parasitology 2004, 129:439-444.
81. Health Canada, 1998. Government action on Krever Commission recommendations. (Online ). http://www.hcsc.gc.ca/english/media/relerases/1998/9889bke1.htm.
82. Howard, J.E., 1962. La enfermedad de Chagas congenita. Tesis. Universidad de Chile. Santiago. p 55.
83. Howard J.E., Rubio M. Enfermedad de Chagas congenita.I. Estudio clinico y epidemiologico de 30 casos. Bol. Chil. Parasitol. 1968, 23:107-112. http://new.paho.org/hq/index/php?option=com_content&task=view&ld =1466&Itemid=1270&lang=en.Acceso 3-12-10, 2009.
84. Jackson Y., Myers C., Diana A., Marti H.P., Wolff H., Chappuis F., et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg. Infect. Dis. 2009, 15(4):601-603.
85. Junqueira A.C.V., Chiari E., Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for diagnosis of Chagas disease patients in a north-eastern endemic region of Brazil. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:129-132.
86. Kirchhoff L.V., Gam A.A., Gusmão R.A., Goldsmith R.S., Rezende J.M., Rassi A. Increased specificity of serodiagnosis of Chagas disease by detection of antibody to the 72 and 90 kilodalton glycoproteins of Trypanosoma cruzi. J. Infect. Dis. 1987, 155:561-564.
87. Knierim F., Saavedra P. Técnica de la reacción de hemaglutinación aplicada al diagnóstico serológico de las parasitosis. Bol. Chil. Parasit. 1966, 21:39-44.
88. Krettli A.U., Brener Z. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J. Immunol. 1982, 128:2009-2112.
89. Leiby D.A., Fucci M.H., Stumpf R.J. Trypanososma cruzi in a low-to moderate-risk blood donor population: seroprevalence and possible congenital transmission. Transfusion 1999, 39:310-317.
90. Leiby D.A., Wendel S., Takaoka D.T., Fachini R.M., Oliveira L.C., Tibbals M.A. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J. Clin. Microbiol. 2000, 38:639-642.
91. Lisboa A.L. Sobre a forma congênita da doença de Chagas. Estudo anatomopatológico de seis casos. Rev. Inst. Med. Trop. São Paulo 1960, 2:319-334.
92. Lorca M., Lorca J., Child R., et al. Prevalencia de la infección por Trypanosoma cruzi en pacientes politransfundidos. Rev. Med. Chil. 1988, 116:112-116.
93. Lorca M.H., Child R.B., Garcia A.C., Silva M.G., Osorio J.S., Atias M. Evaluacion de reactivos comerciales empleados en el diagnostico de la enfermedad de Chagas en bancos de sangre de Chile.I Seleccion de reactivos. Rev. Med. Chil. 1992, 120:420-426.
94. Lorca M.H., Child R.B., Garcia A.C., Silva M.G., Martinez P.L., Jerez G.M., et al. Evaluacion de reactivos comerciales empleados en el diagnostico de la enfermedad de Chagas en bancos de sangre de Chile. II Aplicacion rutinaria. Rev. Med. Chil. 1994, 122:925-931.
95. Lorca M., Veloso C.I., Munoz P., Bahamonde M.I., Garcia A. Diagnostic value of detecting specific IgA and IgM with recombinant Trypanososma cruzi antigens in congenital Chagas disease. Am. J. Trop. Med. Hyg. 1995, 52:512-515.
96. Lorca M., Bahamonde M.I., Garcia A., Tassara R., Urarte E., Contreras M., et al. Infección materna y transmisión transplacentaria del T. cruzi en Chile: diagnostico, tratamiento y control. Rev. Soc. Bras. Med. Trop. 2005, 38(Suppl. II):46-48.
97. Luquetti A.O., Rassi A. Tratamiento específico de la enfermedad de Chagas en la fase crónica: Criterios de cura convencionales: xenodiagnostico, hemocultivo y serologia. Rev. Patol. Trop. 1998, 27(Suppl):37-51.
98. Luquetti A.O., Rassi A. Diagnóstico Laboratorial da Infecção pelo Trypanosoma cruzi. Trypanosoma cruzi e Doença de Chagas 2000, 344-378. Guanabara Koogan, Rio de Janeiro, 2° edição. Z. Brener, A.Z. Andrade, M. e Barral-Neto (Eds.).
99. Luquetti A.O., Tavares S.B.N., Oliveira R.A., Oliveira E.C., Vaz M.G.M., Rassi A. Presença de anticorpos específicos da classe IgM nas diferentes formas clínicas da fase crônica da doença de Chagas. Rev. Soc. Bras. Med. Trop. 1996, 29(Suppl. 1):134-135.
100. Luquetti A.O., Ponce C., Ponce E., Esfandiari J., Schijman A., Revollo S., et al. Chagas'disease diagnosis: a multicentric evaluation of Chagas Stat-Pack, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Diagn. Microbiol. Infect. Dis. 2003, 46:265-271.
101. Luquetti A.O., Ferreira A.W., Oliveira R.A., Tavares S.B.N., Rassi A., Dias J.C.P., et al. Congenital transmission of Trypanosoma cruzi in Brazil: estimation of the prevalence based on preliminary results of the national serological survey in small children of 5 years, and other sources. Rev. Soc. Bras. Med. Trop. 2005, 38(Suppl. 2):24-26.
102. Luquetti A.O., Tavares S.B.N., Oliveira R.A., Siriano L.R., Costa D.G., Oliveira E.C., et al. Sorologia como critério de cura em pacientes tratados com benznidazol. Títulos obtidos em chagásicos não tratados por imunofluorecência indireta. Rev. Soc. Bras. Med. Trop. 2008, 41(Suppl. 3):242-243.
103. Luquetti A.O., Espinoza B., Martinez I., Hernández-Becerril N., Ponce C., Ponce E., et al. Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples. Mem. Inst. Oswaldo Cruz 2009, 104:797-800.
104. Luz Z.M.P., Coutinho M.G., Cançado J.R., Krettli A.U. Hemocultura: técnica sensível na detecção do Trypanosoma cruzi em pacientes chagásicos na fase crônica da doença de Chagas. Rev. Soc. Bras. Med. Trop. 1994, 27:143-148.
105. Maekelt G.A. Die Komplementbindungs reaktion der Chagaskrankheit. Zeit. Tropenmed. Parasit. 1960, 2:152-186.
106. Maekelt G.A. Diagnostico de laboratorio de la Trypanosomiasis Americana. Rev. Venez. Sanid. 1964, 29:1-18.
107. Manitove J.E. Haemovigilance systems. Vox. Sang. 1999, 77:110-120.
108. Martins-Filho O.A., Pereira M.E.S., Carvalho J.F., Cançado J.R., Brener Z. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease. Clin. Diagn. Lab. Immunol. 1995, 2:569-573.
109. Mendes R.P., Hoshino-Shimizu S., Silva A.M.M., Mota I., Heredia R.A.G., Luquetti A.O., et al. Serological diagnosis of Chagas disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi. J. Clin. Microbiol. 1997, 35:1829-1834.
110. Normas de segurança para infecções acidentais com o Trypanosoma cruzi, agente causador da doença de Chagas. Rev. Patol. Trop. 1997, 26:129-130. Ministério da Saúde, Fundação Nacional da Saúde, Gerência Técnica de Doença de Chagas.
111. Ministério da Saúde, Coordenação de DST/AIDS e COSAH, 1998. Telelab No.11. Doença de Chagas-Triagem e diagnóstico sorológico em unidades hemoterápicas e laboratórios de saúde pública. Brasília, Manual, 75 p.
112. Resultado da avaliacao dos kits para diagnostico da doenca de Chagas. Nota Tecnica 2006, 03/06. Ministerio da Saude.
113. Ministerio de Salud Publica y Asistencia Social, Guatemala, 2008. Informe de la situacion sobre el control de la enfermedad de Chagas en Guatemala y propuesta para la certificacion de la interrupcion de la transmision vectorial por Rhodnius prolixus. Agosto, 2008.
114. Moncayo A., Luquetti A.O. Multicentre double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents. Mem. Inst. Oswaldo Cruz 1990, 85:489-495.
115. Mora M.C., Sanchez Negrette O., Marco D., Barrio A., Ciaccio M., Segura M.A., et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J. Parasitol. 2005, 91:1468-1473.
116. Muñoz J., Portus M., Corachan M., Fumado V., Gazcon J. Congenital Trypanosoma cruzi infection in nonendemic area. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1161-1162.
117. Nisida I.V., Amato Neto V., Braz L.M., Duarte M.I., Umezawa E.S. A survey of congenital Chagas' Disease, carried out at three health institutions in Sao Paulo city, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2005, 41:305-311.
118. Oelemann W.M.R., Teixeira G.M., Verissimo da Costa G.C., Borges-Pereira J., De Castro J.D.F., Coura J.R., et al. Evaluation of three commercial enzyme-linked immuno-sorbent assays for diagnosis of Chagas' disease. J. Clin. Microbiol. 1998, 36:2423-2427.
119. Oficina Sanitaria Panamericana, 2003. XIIa Reunion Intergubernamental INCOSUR/Chagas, Santiago, Chile, Marzo.
120. Oknaian S., Remesar M., Ferraro L., del Pozo A.E. Evaluacion externa del desempeno en el tamizaje de bancos de sangre en Argentina: resultados y estrategias para mejorarlo. Rev. Panam. Salud Publica 2003, 13:149-158.
121. Oliveira E.C., Stefani M.M.A., Luquetti A.O., Vencio E.F., Moreira M.A.R., Souza C., et al. Trypanosoma cruzi and experimental Chagas disease: characterization of a stock isolated from a patient with associated digestive and cardiac form. Rev. Soc. Bras. Med. Trop. 1993, 26:25-33.
122. Regimen Legal de Bancos de Sangre en America Latina: Malaria, Chagas y Hepatittis B. Documentos de Trabajo 1993, Organizacion Panamericana de la Salud, Organizacion Panamericana de la Salud.
123. Estandares de Trabajo Para Bancos de Sangre 1999, Organizacion Panamericana de la Salud, Division de Desarrollo de Sistemas de Salud, OPS, Washington DC.
124. Organizacion Panamericana de la Salud, 2000. IV Evaluacion internacional del programa de control de la enfermedad de Chagas en Argentina, Agosto 2000.
125. Estimación Cuantitativa de la Enfermedad de Chagas en las Americas 2006, Organización Panamericana de la Salud, Organización Panamericana de la Salud, OPS/HDM/CD/425-06.
126. Suministro de Sangre Para Transfusiones en los Paises del Caribe y Latinoamerica en 2005 2007, Organización Panamericana de la Salud, Organización Panamericana de la Salud, THS/EVI-2007/01E.
127. Elegilibilidad Para la Donacion de sangre 2009, Organizacion Panamericana de la Salud, Organizacion Panamericana de la Salud, Washington DC.
128. Organización Panamericana de la Salud, 2009. Suministro de sangre para transfusiones en los paises del Caribe y de Latinoamerica en 2006 y 2007. Publicacion THR/HT/2009/01 ESP.
129. Otani, M.M. 2003. Programa de avaliacao externa para os testes de triagem sorologica de doadores de banco de sangue dos centros de referencia da America Latina: utilizacao de multipainel especifico. Thesis, University of Sao Paulo.
130. Pehrson P.O., Wahlgren M., Bengtsson E. Asymptomatic congenital Chagas'disease in a five-year-old child. Scand. J. Infect. Dis. 1981, 13:307-308.
131. Peralta JM, Magalhães TC, Abreu L, Manigot DA, Luquetti A, Dias J.C.P. The direct agglutination test for chronic Chagas's disease. The effect of pre-treatment of test samples with 2-mercaptoethanol. Trans. Roy. Soc. Trop. Med. Hyg. 1981, 75:695-698.
132. Peralta J.M., Teixeira M.G., Shreffler W.G., Pereira J.B., Burns J.M., Sleath P.R., et al. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. J. Clin. Microbiol. 1994, 32:971-974.
133. Perez A., Segura E.L. Transfusión de sangre y transmission de la infección chagásica en Argentina. Rev. Arg. Transf. 1989, 15:127-132.
134. Ponce C, Ponce E, Vinelli E, Montoya R, Aguilar V, González A, et al. Validation of a rapid and reliable test for diagnosis of Chagas disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J. Clin. Micr. 2005, 43:5065-5068.
135. Primavera K.S.C., Umezawa E.S., Peres B.A., Camargo M.E., Shimizu S.H. Chagas' disease: IgA, IgM and IgG antibodies to T. cruzi amastigote, trypomastigote and epimastigote antigens in acute and in different chronic forms of the disease. Rev. Inst. Med. Trop. São Paulo 1990, 32:172-180.
136. Programa de evaluacion externa del desempeño en serología, 2008. America Latina, OPS0207. 10 de Enero, 2008.
137. Programa de evaluacion externa del desempeño en serología, 2009. America Latina, OPS0207. 10 de Febrero, 2009.
138. Rabelo A., Luquetti A.O., Moreira E.F., Gadelha M.F., Santos J.A., Melo L., et al. Serodiagnosis of Trypanosoma cruzi infection using the new particle gel immunoassay-ID-PaGIA Chagas. Mem. Inst. Oswaldo Cruz 1999, 94:77-82.
139. Rassi A., Borges C., Koberle F., Paula O.H. Sobre a transmissao congenital da doenca de Chagas. Rev. Goiana Med. 1958, 4:319-332.
140. Rassi A., Luquetti A.O. Therapy of Chagas disease. Chagas Disease(American Trypanosomiasis), Its Impact on Tranfusion and Clinical Medicine 1992, 237-247. Sociedade Brasileira de Hematologia e Hemoterapia, São Paulo. S. Wendel, Z. Brener, M.E. Camargo, A. Rassi (Eds.).
141. Rassi A., Luquetti A.O. Specific treatment for Trypanosoma cruzi infection (Chagas disease). American Trypanosomiasis 2003, 117-125. Kluwer Academic Publishers, Boston. K.M. Tyler, M.A. Miles (Eds.).
142. Rassi A., Lustosa E.S., Carvalho M.E.S.D., Nascimento M.D., Ferrioli Filho F., Luquetti A.O. Sensibilidade do xenodiagnóstico em pacientes na fase crônica da doença de Chagas. Resultados preliminares. Rev. Soc. Bras. Med. Trop. 1991, 24(Suppl. 1):36-37.
143. Rassi A., Luquetti A.O., Rassi A., Rassi S.G., Rassi A.G. Chagas disease-clinical features. Chagas Disease(American Trypanosomiasis), Its Impact on Tranfusion and Clinical Medicine 1992, 81-101. Sociedade Brasileira de Hematologia e Hemoterapia, São Paulo. S. Wendel, Z. Brener, M.E. Camargo, A. Rassi (Eds.).
144. Rassi A., Luquetti A.O., Rassi A., Rassi G.G., Rassi S.G., Silva I.G., et al. Short report: specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas Disease. Am. J. Trop. Hyg. 2007, 76:58-61.
145. Remezar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, et al. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors of Argentina. Transfusion 2009.
146. Rezende, J.M. & Luquetti, A.O., 1994. Chagasic Megavisceras. In: Chagas' Disease and the Nervous System. Chapter 7. Scientific Publication No.547. Ed. Pan American Health Organization, Washington DC, pp. 149-171.
147. Riera C., Guarro A., El-Kassab H., Jorba J.M., Castro M., Angril R., et al. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am. J. Trop. Med. Hyg. 2006, 75:1078-1081.
148. Rios C.R. Regimen Legal de Bancos de Sangre en America Latina: Malaria, Chagas y Hepatitis B 1992, Organizacion Panamericana de la Salud, Serie Informes Tecnicos No. 18.
149. Rohwedder R.W. Infección chagásica en dadores de sangre y las probabilidades de transmitirla por medio de la transfusión. Bol. Chil. Parasitol. 1969, 24:88-93.
150. Russomando G., Figueredo A., Almiron M., Sakamoto M., Morita K. Polymerase chain reaction-based detection of DNA in serum. J. Clin. Microbiol. 1992, 30:2864-2868.
151. Russomando G., de Tomassone M.M., de Guillen I., Acosta N., Vera N., Almiron M., et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 1998, 59:487-491.
152. Russomando G., Almiron M., Candia N., Franco L., Sanchez Z., Guillen I. Implementación de un sistema localmente sustentable de diagnostico prenatal que permite detectar casos de transmisión congénita de la enfermedad de Chagas en Paraguay. Rev. Soc. Bras. Med. Trop. 2005, 38(Suppl. 2):49-57.
153. Saez-Alquezar A., Luquetti A.O., Borges-Pereira J., Furtado E.M., Gadelha M.F.S., Garcia-Zapata M.T., et al. Estudo multicéntrico: avaliacao do desempenho de conjuntos diagnosticos de hemaglutinacao indireta, disponiveis no Brasil, para o diagnostico sorologico da infeccao pelo Trypanosoma cruzi. Rev. Patol. Trop. 1997, 26:343-374.
154. Saez-Alquezar A., Otani M.M., Sabino C.C., Ribeiro dos Santos G., Salles N., Chamone D.F. Evaluation of the performance of Brazilian blood banks in testing for Chagas'diseases. Vox. Sang. 1998, 74:228-231.
155. Saez-Alquezar A., Otani M.M., Sabino C.C., Salles N.A., Dalton Chamone D.F. Programa de control externo de la calidad en serologia desarrollados en America Latina con el apoyo de la OPS entre 1997 y 2000. Rev. Panam. Salud Publica 2003, 13:91-102.
156. Salas N.A., Cot M., Schneider D., Mendoza B., Santalla J.A., Postigo J., et al. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop. Med. Int. Hlth. 2007, 12:1498-1505.
157. Salgado AA, Mayrink W, Dias J.C.P. Estudo comparativo entre a reacao do fixacao do complemento com os antigenos benzeno-cloroformado e metilico e o xenodiagnostico. Rev. Inst. Med. Trop. Sao Paulo 1970, 12:36-40.
158. Santos A.H., Silva I.G., Rassi A. Estudo comparativo entre o xenodiagnóstico natural e o artificial em chagásicos crônicos. Rev. Soc. Bras. Med. Trop. 1995, 28:367-373.
159. Sarasúa W.M. Detección de la transmission congénita
160. Scharfstein J., Luquetti A., Murta A.C.M., Senna M., Rezende J.M., Rassi A., et al. Chagas disease: serodiagnosis with purified Gp25 antigen. Am. J. Trop. Med. Hyg. 1985, 34:1153-1160.
161. Schechter M., Luquetti A.O., Rezende J.M., Rassi A., Miles M.A. Further evaluation of lectin affinity purified glycoprotein (GP90) in the enzyme linked immunosorbent assay (ELISA) for diagnosis of Trypanosoma cruzi infection. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:637-640.
162. Schechter M., Stevens A.F., Luquetti A.O., Snary D., Allen A.K., Miles M.A. Prevalence of antibodies to 72-kilodalton glycoprotein (GP72) in patients with Chagas'disease and further evidence of zymodeme-associated expression of GP72 carbohydrate epitopes. Infect. Immun. 1986, 53:547-552.
163. Schijman A.G. RT-PCR in the diagnosis of Chagas disease: an overview of the workshop sponsored by PAHO/WHO. Rev. Patol. Trop. 2009, 38(Suppl. 2 CDRom):1411-1412.
164. Schijman A.G., Altcheh J., Burgos J.M., Biancardi M., Bisio M., Levin M.J., et al. Aetiological treatment of congenital Chagas disease diagnosed and monitored by the polymerase chain reaction. J. Antimicrob. Chemother. 2003, 52:441-449.
165. Schlemper B.R. Estudos experimentais de quimioprofilaxia da transmissão da doença de Chagas por transfussão sanguinea. Rev. Patol. Trop. 1978, 7:55-111.
166. Schmunis G., Szarfman A. Enfermedad de Chagas congenita. Medicina (B. Aires) 1977, 37:47-53.
167. Schmunis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991, 31:547-572.
168. Schmuñis G.A. A resposta imune-humoral na infecção humana recente pelo Trypanosoma cruzi. Rev. Patol. Trop. 1991, 20:51-146.
169. Schmunis G.A. Epidemiology of Chagas disease in nonendemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 2007, 102(Suppl. 1):75-85.
170. Schmunis G.A. American Trypanosomiasis as a public health problem. Chagas Disease and the Nervous System 1994, PAHO, Sci Pub No.547, pp. 3-29.
171. Schmunis G.A., Cruz J.R. Safety of the blood supply in Latin America. Clin. Microbiol. Rev. 2005, 18:12-29.
172. Schmunis G.A., Zicker F., Pinheiro F., Brandling-Bennett D. Risk of transfusion transmitted infectious diseases in Central and South America. Emerg. Infect. Dis. 1998, 4:5-11.
173. Schmunis G.A., Zicker F., Del Pozo A., Segura E. Blood transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion 2000, 40:1048-1053.
174. Schmunis G.A., Zicker F., Cruz J.R., Cuchi P. Safety of the blood supply for infectious diseases in Latin Américan countries. Am. J. Trop. Med. Hyg. 2001, 65:924-930.
175. Silveira J.F., Umezawa E.S., Luquetti A.O. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol. 2001, 17:286-291.
176. Siqueira A.F. Comparação de antigenos de Trypanosoma cruzi para reações quantitativas de fixação do complemento. II. Analise sequencial de probabilidade direta aplicada ao sistema moléstia de Chagas. Rev. Inst. Med. Trop. Sao Paulo 1964, 6:268-276.
177. Sosa Estani S. Transmision congenita del Trypanosoma cruzi en Argentina. Rev. Soc. Brasil. Med. Trop. 2005, 38(Suppl. II):29-32.
178. Sosa Estani S., Segura E.L., Ruíz A.M., Velázquez E., Porcel B.M., Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am. J. Trop. Med. Hyg. 1998, 59:526-529.
179. Stagno S., Hurtado R. Trypanososma cruzi: una nueva causa de infección congénita capaz de inducir la formación de antricuerpos IgM. Bol. Chil. Parasitol. 1970, 25:90-91.
180. Stagno S., Hurtado R. Enfermedad de Chagas congenita. Estudio immunologico y diagnostico mediante inmunofluorescencia con IgM. Bol. Chil. Parasitol. 1971, 26:20-27.
181. Streiger M., Fabbro B., Del Barco M., Beltramino R., Bovero N. Chagas congenito en la ciudad de Santa Fe, diagnostico y tratamiento. Medicina (Bs Aires) 1995, 55:125-133.
182. Stolf A.M.S. Serological diagnosis-Trypanosoma cruzi antigens in serodiagnosis. Chagas Disease (American Trypanosomiasis), Its Impact on Tranfusion and Clinical Medicine 1992, 195-205. Sociedade Brasileira de Hematologia e Hemoterapia, São Paulo. S. Wendel, Z. Brener, M.E. Camargo, A. Rassi (Eds.).
183. Stolf A.M.S., Umezawa E.S., Zingales B. Simultaneous identification of Trypanosoma cruzi surface and internal antigens reactive to different immunoglobulin classes (Radio-immunoblotting). Rev. Inst. Med. Trop. São Paulo 1990, 32:370-383.
184. Strout R.G. A method for concentrating hemoflagellates. J. Parasitol. 1962, 48:100.
185. Sturm N.R., Degrave W., Morel C., Simpson L. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease. Mol. Biochem. Parsitol. 1989, 33:205-214.
186. Szarfman A., Otati L, Schmunis G., Vilches A. A simple method for the detection of human congenital Chagas disease. J. Parasitol. 1973, 59:723.
187. Szarfman A., Urman J., Otalora A., Larguia A., Yanovsky J.F. Specific agglutinins and immunoglobulin levels in congenital Chagas infection. Medicina (B Aires) 1975, 35:245-250.
188. Teixeira A.R., Figueiredo F., Rezende-Filho J. Hipersensibilidade tardia a antígeno de Trypanosoma cruzi: II emprego do teste cutâneo com antígeno T12E para diagnóstico da doença de Chagas. Rev. Soc. Bras. Med. Trop. 1995, 28:259-265.
189. Teixeira M.G., Borges-Pereira J., Netizert E., Souza M.L., Peralta J.M. Development and evaluation of and enzyme linked immunotransfer blot technique for serodiagnosis of Chagas disease. Trop. Med. Parasitol. 1994, 45:308-312.
190. Torrico F., Alonso-Vega C., Suarez E., Rodriguez P., Torrico M.C., Dramaix M., et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am. J. Trop. Med. Hyg. 2004, 70:201-209.
191. Umezawa E.S., Nascimento M.S., Kesper N., Coura J.R., Borges-Pereira J., Junqueira A.C.V., et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J. Clin. Microbiol. 1996, 34:2143-2147.
192. US Food and drug Administration, 2006. FDA approves first test to screen blood donors for Chagas disease. Available at:. Accessed March 10, 2007. http://www.fda.gov/bbs/topics/NEWs/2006/NEW01524.html.
193. Valerio-Wanderley D.M., Moraes e Souza H., Gonzalez T.T., Pereira M.S.C.A. Inquerito sobre a situação do controle do sangre no estado de São Paulo. Rev. Soc. Bras. Med. Trop. 1992, 25(Suppl.):35.
194. Vasquez J.E., Krusgell J, Orn A., Sousa O.E., Harris R.A. Serological diagnosis of Trypanosoma rangeli infected patients. A comparison of different methods and its implications for the diagnosis of Chagas disease. Scand. J. Immunol. 1997, 45:322-330.
195. Vattuone N.H., Yanovsky J.F. Trypanosoma cruzi: agglutination activity of enzyme treated epimastigotes. Exp. Parasitol. 1971, 30:349-355.
196. Venkatesa P., Wakelin D. ELISAs for parasitologists: or lies, damned lies and ELISAs. Parasitol. Today 1993, 9:228-232.
197. Vickerman K. The diversity of the Kinetoplastid flagellates. Biology of the Kinetoplastida 1976, vol. I:1-34. Academic Press, London.
198. Vitelli-Avelar D.M., Sahtler-Avelar R., Wendling A.P.B., Rocha R.D.R., Teixeira-Carvalho A., Martins N.E., et al. Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in clinical laboratory. J. Immunol. Methods 2007, 318:102-112.
199. Voller A., Draper C., Bidwell D.E., Bartlett A. A microplate enzyme-linked immunosorbent assay (ELISA) for Chagas disease. Lancet 1975, 1:426-429.
200. Wendel S., Pinto Dias J.C. Transfusion transmitted Chagas' disease. Chagas' Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine 1992, 103-133.
201. Control of Chagas' disease report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 1991, 811. World Health Organization.
202. Control of Chagas' disease report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 2002, 905. World Health Organization.
203. World Health Organization, 2006. Neglected Tropical Diseases. Hidden successes, emerging opportunities. Ed.WHO, WHO/CDS/NTD/2006.2, Geneva.
204. Yun O., Lima M.A., Ellman T., Chambi W., Castilho S., Flevaud L., et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolívia: 10-year experience of Mèdecins Sans Frontières. PLoS Negl. Trop. Dis. 2009, 3:e488. doi:10.1371/journal.pntd.0000488.
205. Zaidenberg M. La enfermedad de Chagas congénita en la provincial de Salta, Argentina, años 1980-1997. Rev. Soc. Bras. Med. Trop. 1999, 32:689-695.
206. Zeledon R., Ponce C. A skin test for the diagnosis of Chagas' disease. Trans. R. Soc. Trop. Med. Hyg. 1974, 68:414-415.
207. Zeledon R., Dias J.C.P., Salazar B.A., Rezende J.M., Vargas L.G., Urbina A. Does a spontaneous cure for Chagas diseases exist?. Rev. Soc. Bras. Med. Trop. 1988, 21:15-20.
208. Zicker F., Smith P.G., Luquetti A.O., Oliveira O.S. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper. Bull. World Health Org. 1990, 68:465-471.
209. Zingales B., Andrade S.A., Briones M.R.S., Campbell D.A., Chiari E., Fernandes O., et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 2009, 104:1051-1054.
210. Zuna, H., 1983. Estudio de la importancia de la transmisión de la enfermedad de Chagas por via transfusional. Experiencia de Santa Cruz, Bolivia, 1982-1983. In: Anales Colóquio Internacional Enfermedad de Chagas. Santa Cruz de la Sierra, Bolivia.